Paul Tudor Jones’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Paul Tudor Jones’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,445	Closed	-$570K	–	1335
2018 Q3	$570K	Buy	+10,445	New	+$714K	0.01%	648
2018 Q1	–	Sell	-8,864	Closed	-$456K	–	1365
2017 Q4	$456K	Sell	8,864 -35	-0.4%	-$2.51K	0.01%	647
2017 Q3	$793K	Buy	+8,899	New	+$676K	0.02%	474
2016 Q3	–	Sell	-22,500	Closed	-$1.15M	–	1840
2016 Q2	$1.15M	Buy	+22,500	New	+$961K	0.02%	395
2016 Q1	–	Sell	-42,530	Closed	-$1.93M	–	2066
2015 Q4	$1.93M	Buy	+42,530	New	+$2.23M	0.05%	226
2015 Q2	–	Sell	-2,855	Closed	-$221K	–	1753
2015 Q1	$221K	Buy	+2,855	New	+$164K	0.01%	1242

Other funds holding ONCE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Paul Tudor Jones's ONCE Position: Q4 2018 in Review

Paul Tudor Jones sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2018, closing a stake of 10,445 shares — an estimated $570K sold.

Paul Tudor Jones first reported a position in ONCE in Q1 2015 and held it in 6 quarters. The position peaked at $1.93M in Q4 2015. 157 funds tracked by Wall St. Rank hold ONCE as of Q4 2018.

Paul Tudor Jones reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Paul Tudor Jones sold 10,445 Spark Therapeutics, Inc. Common Stock shares in Q4 2018, an estimated $570K.
Paul Tudor Jones first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 6 quarters.
Paul Tudor Jones's Spark Therapeutics, Inc. Common Stock position peaked at $1.93M in Q4 2015.
157 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2018.

Based on Tudor Investment Corp's 13F filing for Q4 2018, filed 14 Feb 2019.